Autonomix Medical, Inc. (AMIX) Stock Price & Analysis
Autonomix Medical, Inc. (AMIX) rose 0.62% to USD 0.4 as of June 10, 2026 at 05:27 UTC, according to Nexqual real-time market data.
AMIX last closed at USD 0.4; the session ranged USD 0.38–0.41 on volume of 84,934 shares. Market capitalization is $4.62M, with a 52-week range of USD 0.2–2.64 (NCM). Source: Nexqual, June 10, 2026 at 05:27 UTC.
Key Statistics (as of June 10, 2026 at 05:27 UTC)
| Price | USD 0.4 |
|---|---|
| Change | ▲ 0.62% (up) |
| Previous Close | USD 0.4 |
| Open | USD 0.41 |
| Day Range | USD 0.38 – 0.41 |
| 52-Week Range | USD 0.2 – 2.64 |
| Volume | 84,934 shares |
| Market Cap | $4.62M |
| Exchange | NCM |
Technical Analysis (AMIX)
Nexqual's technical model rates AMIX "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 05:27 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 55.2 (neutral) |
| vs SMA50 | Above (USD 0.38) |
| MACD | 0.01 (positive) |
Analyst Ratings (AMIX)
Wall Street analysts rate AMIX "Strong Buy" based on 2 analysts, with a mean price target of USD 2.8 (range USD 2–3.6), per Nexqual as of June 10, 2026 at 05:27 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 2.8 |
| High Target | USD 3.6 |
| Low Target | USD 2 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (AMIX)
| Revenue Estimate | $0 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.36 vs est -0.46 ▲ beat |
| 2025-09-30 | USD -1.38 vs est -1.5 ▲ beat |
| 2025-06-30 | USD -1.07 vs est -0.98 ▼ miss |
Source: Nexqual, June 10, 2026 at 05:27 UTC.
Financials & Fundamentals (AMIX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -238.89% |
| Current Ratio | 4.45 |
| Total Cash | $7.00M |
| Total Debt | $0 |
| Free Cash Flow | $-6.49M |
Source: Nexqual, June 10, 2026 at 05:27 UTC.
Financial Health Score (AMIX)
Nexqual rates Autonomix Medical, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:27 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $7M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$12M |
| Efficiency | Critical — ROE -239%, ROA -122.3% |
Ownership (AMIX)
| Insider Ownership | +4.06% |
|---|---|
| Institutional Ownership | +4.15% |
| Shares Outstanding | 11.41M |
| Float | 11.06M |
| Short % of Float | +5.73% |
Source: Nexqual, June 10, 2026 at 05:27 UTC.
Leadership (AMIX)
Autonomix Medical, Inc. is led by Bradley Hauser (age 48), CEO & President, per Nexqual as of June 10, 2026 at 05:27 UTC.
| CEO & President | Bradley Hauser (age 48) |
|---|---|
| Executive Chairman | Walter V. Klemp (age 65) |
| Executive Vice Chairman | Lori H. Bisson (age 54) |
| Co-Founder & Chief Technology Officer | Landy Toth (age 48) |
| Co-Founder & Director | David A. Robins (age 56) |
Major Backers & Investors (AMIX)
Notable institutional backers of Autonomix Medical, Inc. include Fidelity, Mariner, LLC, UBS Group AG, according to Nexqual as of June 10, 2026 at 05:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 1.52% |
| Mariner, LLC | 0.46% |
| UBS Group AG | 0.29% |
| LPL Financial LLC | 0.28% |
| Bank of Montreal /CAN/ | 0.22% |
| Ikarian Capital, LLC | 0.16% |
| Virtu Financial LLC | 0.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 1.54% |
Source: Nexqual, June 10, 2026 at 05:27 UTC.
From Autonomix Medical, Inc.'s Latest SEC 10-K Filing (filed 2026-05-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
- The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
- It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AZTR | Azitra Inc | USD 0.21 | ▲ 0.62% |
| MIRA | MIRA Pharmaceuticals, Inc. | USD 0.98 | ▼ 2.3% |
| VSEE | VSee Health, Inc. | USD 0.16 | ▼ 1.19% |
| IVPR | Inspire Veterinary Partners Inc | USD 0 | ▼ 35% |
| TRNR | Interactive Strength Inc. | USD 0.7 | ▼ 6.21% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:27 UTC. This page is informational and not investment advice.